SLA 0.00% $3.34 silk laser australia limited

holding up well, page-66

  1. 90 Posts.
    " ropren can be recommended as an effective hepatprotector for treatment of hepatobiliary system damage, and for treatment of chronic hepatitis, cirrhosis ( in combinned therapy)and fatty dsytrophy of the liver of various aetiology"

    http://www.solagran.com/cikk_files/pasteur_journal_small.pdf?PHPSESSID=a4d93e57e35b47df5ec8b0dc3a135f1c
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.